Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KLRA Kailera Therapeutics

Pre-Mkt 09-03 06:57:59 EDT

15.85

-0.56

-3.41%

盘前15.81

-0.04-0.25%

04:58 EDT

High16.82	Low15.59	Vol737.27K
Open16.39	D1 Closing16.41	Amplitude7.50%
Mkt Cap2.05B	Tradable Cap712.01M	Total Shares129.54M
T/O11.70M	T/O Rate1.64%	Tradable Shares44.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics","latestPrice":15.85,"timestamp":1788379200000,"preClose":16.41,"halted":0,"volume":737265,"hourTrading":{"tag":"盘前","latestPrice":15.81,"preClose":15.85,"latestTime":"04:58 EDT","volume":1,"amount":15.81,"timestamp":1788425881389,"change":-0.04,"changeRate":-0.002524,"amplitude":0},"delay":0,"changeRate":-0.034125533211456456,"floatShares":44921899,"shares":129537300,"eps":-2.254252,"marketStatus":"Pre-Mkt","change":-0.56,"latestTime":"09-03 06:57:59 EDT","open":16.39,"high":16.82,"low":15.59,"amount":11704314.85074,"amplitude":0.074954,"askPrice":17.5,"askSize":700,"bidPrice":13.16,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.254252,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":15.85,"preHourTrading":{"tag":"盘前","latestPrice":15.81,"preClose":15.85,"latestTime":"04:58 EDT","volume":1,"amount":15.81,"timestamp":1788425881389,"change":-0.04,"changeRate":-0.002524,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":15.85,"preClose":15.85,"latestTime":"19:30 EDT","volume":3826,"amount":60641.15,"timestamp":1788391806479,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8972227731805386},"requestUrl":"/m/hq/s/KLRA/tweets","defaultTab":"tweets","newsList":[{"id":"2659818171","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659818171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659818171?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:10","pubTimestamp":1786579809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on P3 Health Partners (PIII) and Kailera Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-p3-health-partners-piii-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-p3-health-partners-piii-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","OZEM","KLRA","LU0029874061.USD","BK4137","PIII","XLV","LABU","BK4196","BK4588","HCSG","BK4585","BK4139","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659850186","title":"Kailera Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659850186","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659850186?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:22","pubTimestamp":1786573367,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryKailera Therapeutics IncKLRA.OQreported a quarterly adjusted loss of $1.09 per share for the quarter ended June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4492B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA","OZEM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188516","title":"Kailera Therapeutics Q2 EPS $(1.09) Misses $(0.74) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188516","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188516?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:39","pubTimestamp":1786567145,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.74) by 47.3 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61160351/kailera-therapeutics-q2-eps-1-09-misses-0-74-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kailera Therapeutics Q2 EPS $(1.09) Misses $(0.74) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074999","title":"Kailera Q2 FY26 Net Loss Widens to $111.31 Million; R&D Expenses Climb to $101.06 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074999","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074999?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565148,"startTime":"0","endTime":"0","summary":"Kailera Q2 FY26 net loss widens to $111.31 million; R&D expenses climb to $101.06 millionKailera posted a net loss of USD 111.31 million, widening from USD 28.95 million a year earlier.R&D expenses mo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbzlZ13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","KLRA","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BCDF","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","SG9999014021.USD","NDAQ","BK4139","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","OZEM","SG9999014039.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659670188","title":"Kailera Therapeutics - Phase 2B High-Dose Ribupatide Injection Trial Fully Enrolled; Data Expected Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659670188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659670188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA2YC1DX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OZEM","BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659605188","title":"Kailera Therapeutics - Ind Application for Ribupatide Oral Active with FDA; Phase 3 Obesity Trials Planned First Half 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2659605188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659605188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA2YC1DX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLRA","OZEM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659290711","title":"Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659290711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659290711?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA2YC1DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OZEM","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992804","title":"Kailera Therapeutics Names Nur Nicholson Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992804","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992804?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:05","pubTimestamp":1786446310,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics names Nur Nicholson chief technology officerKailera Therapeutics named Nur Nicholson chief technology officer, effective Aug. 31, 2026.Role centers on scaling manufacturing and su","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL2PFshn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BMED","BK4585","IE00BGHQF748.EUR","BK4588","LU0109394709.USD","BIIB","IE00B64PRP62.GBP","LU2210150020.SGD","BK4533","SG9999014039.USD","IE00BKPKM429.USD","BCDF","IE00B19Z9P08.USD","LU0314104364.USD","IE00BN0W2T93.GBP","PBE","IE00B894F039.SGD","BK4532","LU0234570918.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","SG9999014021.USD","BK4112","KLRA","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","OZEM","IE00B19Z9Z06.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999445","title":"Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999445","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999445?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUAC13XLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLRA","OZEM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658957199","title":"Kailera Therapeutics Inc Expected to Post a Loss of 75 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658957199","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658957199?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:27","pubTimestamp":1786400825,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics Inc <KLRA.OQ> expected to post a loss of75cents a share - Earnings PreviewKailera Therapeutics IncKLRA.OQKLRA.Ois expected to  report resultson August 12 for the period ending Jun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44727M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126637747","title":"Earning Preview: Kailera Therapeutics this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1126637747","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126637747?lang=en_us&edition=fundamental","pubTime":"2026-08-05 10:27","pubTimestamp":1785896846,"startTime":"0","endTime":"0","summary":"Abstract Kailera Therapeutics will report fiscal results on August 12, 2026 Post-Mkt, with the market looking for zero revenue, a forecast adjusted EPS of -0.75, and EBIT of -120.50 million US...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Kailera Therapeutics this quarter’s revenue is expected to increase by 0%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650152659","title":"Kailera Therapeutics Files Form 3 for Chief Corporate Affairs Officer Kathleen Tregoning","url":"https://stock-news.laohu8.com/highlight/detail?id=2650152659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650152659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:16","pubTimestamp":1783541765,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics files Form 3 for Chief Corporate Affairs Officer Kathleen TregoningKailera Therapeutics named Kathleen Tregoning as chief corporate affairs officer in an initial Form 3 filing dat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL8l21D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRA","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099976","title":"Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099976","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649099976?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:35","pubTimestamp":1783517747,"startTime":"0","endTime":"0","summary":"In a report released today, Roger Song from Jefferies maintained a Buy rating on Kailera Therapeutics, Inc., with a price target of $48.00. Song co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649346689","title":"Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649346689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649346689?lang=en_us&edition=fundamental","pubTime":"2026-07-08 01:30","pubTimestamp":1783445416,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA). A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","XLV","BK4588","BK4581","BK4185","BK4585","OZEM","KLRA","XBI","ACHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649402939","title":"Race to Launch Weight-loss Pills Heats up as Smaller Players Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2649402939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649402939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:12","pubTimestamp":1783440755,"startTime":"0","endTime":"0","summary":"FACTBOX-Race to launch weight-loss pills heats up as smaller players advanceAdds details of Kailera Therapeutics' obesity drug in paragraphs 1,2 and 25July 7 (Reuters)-Kailera Therapeutics'KLRA.Ooral ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4391DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1712237335.SGD","BK4599","LU1868837300.USD","LU1037948897.HKD","SG9999018857.SGD","LU0820561909.HKD","LU2023251221.USD","LU2357627491.SGD","JDOC","LU1894683348.USD","LU1720051108.HKD","SG9999015945.SGD","IE00BJLML261.HKD","IXJ","LU0345770308.USD","LU1989772923.USD","SG9999018865.SGD","LU0353189680.USD","LU2471134952.CNY","LU0477156953.USD","VHT","SG9999013999.USD","LU2471134523.USD","LU0154236417.USD","LU2106854487.HKD","LU1066051498.USD","IE00BN8TJ469.HKD","LU1069344957.HKD","LU2461242641.AUD","LU1291159041.SGD","IE00BKDWB100.SGD","LU0943347566.SGD","LU0354030438.USD","LU1969619763.USD","IE000M9KFDE8.USD","IE00BFSS7M15.SGD","SGXZ51526630.SGD","FTXH","LU2111349929.HKD","IE0009355771.USD","RXL","LU1804176565.USD","LU0648001328.SGD","BK4581","LU1629891620.HKD","IE00B4JS1V06.HKD","SG9999014542.SGD","LU0820562030.AUD","LU2491050071.SGD","LU2089284900.SGD","LU1917777945.USD","LU1551013425.SGD","IE00BFSS8Q28.SGD","NVOH","LU0238689110.USD","LU2125909247.SGD","SG9999001176.SGD","LU2168564222.USD","LU1868837136.USD","LU0265550359.USD","MRK","IE00B7KXQ091.USD","SGXZ31699556.SGD","LU1201861249.SGD","LU0354030511.USD","LU1162221912.USD","LU0225771236.USD","IE00BLSP4239.USD","LU2552382132.HKD","LU2360032135.SGD","LU1323610961.USD","IE0005OL40V9.USD","IE00BWXC8680.SGD","ILDR","VKTX","LU2168564149.EUR","GB00BDT5M118.USD","01801","LU0320765992.SGD","IE00BK4W5M84.HKD","LU1623119135.USD","LU0689472784.USD","IE00BFTCPJ56.SGD","IE00BJJMRX11.SGD","ELIS","KLRA","LU0256863902.USD","LU2417539215.USD","SG9999014898.SGD","LU0070302665.USD","LU0265550946.USD","LU2168564495.EUR","GDOC","IE00BKVL7J92.USD","LU2552382058.USD","LU0820561818.USD","LU1116320737.USD","LU0985320562.USD","LU2462157665.USD","HRTS","LU2023250330.USD","LU0965509283.SGD","LU2756315664.SGD","KURE","LU0106261372.USD","LU0170899867.USD","SG9999015978.USD","LU0289739699.SGD","LU1366192091.USD","LU2552382215.SGD","LU0323591593.USD","LU1037948541.HKD","LU1061106388.HKD","LU2357305700.SGD","LU2746668461.USD","LU2896262040.SGD","LU0006306889.USD","LU0471298694.HKD","LU0079474960.USD","LU2433249047.HKD","SG9999014914.USD","LU2237438978.USD","LU2237443978.SGD","LU0417517546.SGD","LU0965509101.SGD","LU0708995401.HKD","LLYX","LU2756315318.SGD","IE0004445015.USD","LU0345770993.USD","LU2328871848.SGD","LU2242644610.SGD","LU1974910355.USD","LLY","IE00B19Z3581.USD","OZEM","BK1515","LU0882574139.USD","PAWZ","LU1069347547.HKD","LU1883839398.USD","WDNA","LU2237443549.SGD","LU0122379950.USD","LU1585245621.USD","LU1548497426.USD","SG9999014575.USD","LU0823434583.USD","LU0708994859.HKD","LU2324357040.USD","LLYZ","LU0094547139.USD","LU0859254822.USD","IE00B19Z3B42.SGD","LU2125154778.USD","SG9999015986.USD","BK4568","LU0158827948.USD","LU0096364046.USD","LU1280957306.USD","LU2471134879.HKD","SG9999015341.SGD","LU1093756168.USD","LU0058720904.USD","BK4592","LU2097828557.USD","SG9999014906.USD","SG9999014559.SGD","LU1571399168.USD","SGXZ81514606.USD","HK0000165453.HKD","IE0002270589.USD","LU0455707207.USD","LU2596442595.SGD","SG9999017495.SGD","IE00BJT1NW94.SGD","SG9999002232.USD","LU0029864427.USD","LU1699723380.USD","BK4588","SG9999015358.SGD","LU0320765646.SGD","LU1941712264.USD","LU2468319806.SGD","LU1934455277.USD","LU0203201768.USD","PPH","LU0683600562.USD","LU1929549753.HKD","LU1868836591.USD","LU0321505868.SGD","LU1035775433.USD","BK1574","LU0133085943.USD","LU0210536198.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","LU0109394709.USD","LU2023250504.SGD","BK4532","IE0001KFT4U8.USD","LU0868494617.USD","IE00B2B36J28.USD","LU1894683264.USD","LU1145028129.USD","LU1814569148.SGD","LU2491049909.HKD","LU0203345920.USD","LU0787776722.HKD","LU2112291526.USD","SG9999001440.SGD","LU1066053197.SGD","LU2361045086.USD","LU0114720955.EUR","LU1093756325.SGD","LU2213496289.HKD","LU1066051225.USD","LU2471134796.USD","LU1064131342.USD","BK4516","BK4550","LU2089283258.USD","LU1720051017.SGD","LU0353189763.USD","LU0882574055.USD","LU2087625088.SGD","LU1232071149.USD","LU2491050154.USD","LU0965508806.USD","BK4585","LU2237443895.HKD","IE00B1XK9C88.USD","LU2361044865.SGD","LU0320765059.SGD","LU2125909593.SGD","LU2746668974.SGD","LU0234572021.USD","LLII","NVOX","CANC","LU2028103732.USD","LU0098860793.USD","LU2264538146.SGD","LU0321505439.SGD","LU1941712348.USD","PFE","LU2237443622.USD","IE0002141913.USD","LU0320765489.SGD","LU1057294990.SGD","BK1583","LU0980610538.SGD","LU0889565916.HKD","BK4533","LU1868836914.USD","LU1127390331.HKD","IHE","BK4139","LU0868494708.USD","LU2456880835.USD","IE00BN29S564.USD","LU0256863811.USD","LU0786609619.USD","LU1934455194.USD","LU1267930730.SGD","LU0225283273.USD","LU0130517989.USD","LU0823434740.USD","LU0466842654.USD","SG9999011175.SGD","IE00BJJMRZ35.SGD","LU0965509010.AUD","LU0471298777.SGD","LU0203202063.USD","LU2271345857.HKD","LU0432979614.USD","LU1430594728.SGD","LU2750360997.AUD","LU2488822045.USD","LU1868836757.USD","LU0225284248.USD","LU0208291251.USD","IE0004445239.USD","BK4007","IE00BSNM7G36.USD","MEDX","LU2089984988.USD","LU0211331839.USD","LU0316494557.USD","BK4534","ELIL","IE00BK4W5L77.USD","IE00BKPKM429.USD","LU1934455863.HKD","GPCR","LU2023250843.SGD","MEDI","IE00BLSP4452.SGD","LU1989772840.SGD","BK1589","LU1023059063.AUD","LU1267930573.SGD","PJP","LU0158827781.USD","LU2361044949.HKD","IE00B3T34201.USD","SGXZ57979304.SGD","LU0502904849.HKD","LU2108987350.USD","SG9999003800.SGD","IE00B4R5TH58.HKD","SG9999015952.SGD","IE00B775H168.HKD","LU0266013472.USD","LU2125154935.USD","LU2602419157.SGD","NVO","LU2237443382.USD","LU0456855351.SGD","XLV","LU2211815571.USD","BK4559","LU0672654240.SGD","LU0306806265.USD","LU0823416689.USD","LU0964807845.USD","LU2265009873.SGD","LU2168563687.JPY","LU2097828631.EUR","LU2236285917.USD","BMED","LU2063271972.USD","LU1983299246.USD","LU2750360641.GBP","LU1989771016.USD","SGXZ99366536.SGD","SG9999001176.USD","THNR","LU0385154629.USD","LU1923622614.USD","LU0985481810.HKD","BK1161","FHLC","LU0640476718.USD","01672","AZNH","LU0942090050.USD","LU1035773651.USD","LU2097828805.USD","CURE","LU1551013342.USD","LU0198837287.USD","LU0109391861.USD","LU1066051811.HKD","LU2237443465.HKD","LU2360106947.USD","IE00BBT3K403.USD","LU0061475181.USD","SG9999014880.SGD","AZN","AGNG","LU0203347892.USD","LU0310800379.SGD","LU0097036916.USD","LU2097828714.EUR","IYH","LU2097828474.EUR","LU2168564065.EUR","IE00BJJMRY28.SGD","LU0130102774.USD","SG9999002224.SGD","SG9999014567.USD","IE00B1BXHZ80.USD","LU1829250122.USD","LU1116320901.HKD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649352259","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649352259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649352259?lang=en_us&edition=fundamental","pubTime":"2026-07-07 22:40","pubTimestamp":1783435211,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kailera Therapeutics, Inc. (KLRA) and Revolution Med...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-246?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-246?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","KLRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649933246","title":"Kailera Therapeutics announces positive Phase 3 data for weight loss drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2649933246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649933246?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:35","pubTimestamp":1783431310,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics (KLRA) announced positive topline results from two Phase 3 clinical trials conducted by its partner, Hengrui Pharma, evaluatin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kailera-therapeutics-announces-positive-phase-3-data-for-weight-loss-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kailera-therapeutics-announces-positive-phase-3-data-for-weight-loss-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GDOC","IDNA","BMED","OZEM","KLRA","MEDX","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984022","title":"Shares of Kailera Therapeutics up 1.9% Premarket After Weight-loss Drug Meets Main Goal of Late-stage Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984022?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:31","pubTimestamp":1783423890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN4390HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OZEM","KLRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649162984","title":"Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2649162984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649162984?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:21","pubTimestamp":1783423300,"startTime":"0","endTime":"0","summary":"UPDATE 3-Kailera shares tumble on high nausea rates despite weight-loss drug's successJuly 7 (Reuters)-Kailera Therapeutics'KLRA.Oshares dropped 10% on Tuesday after its oral weight-loss drug showed h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","LU2293690249.USD","IE0034235188.USD","LU1267930813.SGD","LU1481600234.SGD","LU0405327494.USD","LU1078025761.USD","LU2097828557.USD","LU2237443549.SGD","LU0496365809.HKD","SG9999001176.USD","LU0972486137.USD","LU1267930227.SGD","LU0211327993.USD","LU1880407215.USD","LU2097828631.EUR","BK0188","LU0957799991.USD","LU1781817850.SGD","LU2089284900.SGD","LU0211326839.USD","LU0171276677.USD","LU0310800965.SGD","LU2237443978.SGD","SGXZ57979304.SGD","600276","LU0976567544.SGD","LU0345777659.USD","LU2324357040.USD","LU0784384876.USD","IE00B4R5TH58.HKD","LU0960981461.USD","LU2097828805.USD","LU1273509221.SGD","LU0289739699.SGD","LU1046234339.USD","LU1064130708.USD","LU0203345920.USD","AZN.UK","KLRA","LU1146622755.USD","LU1989771016.USD","03165","LU0949170426.SGD","LU1328615791.USD","LU0266013472.USD","LU0889566641.SGD","LU0526926950.USD","LU2237443622.USD","LU0310799852.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984887","title":"Kailera's GLP-1 Drug Meets Main Goal of Late-stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984887?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:06","pubTimestamp":1783422405,"startTime":"0","endTime":"0","summary":"Kailera's GLP-1 drug meets main goal of late-stage trialsJuly 7 (Reuters)-Kailera TherapeuticsKLRA.Osaid on Tuesday its GLP-1 drug for patients with diabetes and obesity met the main goal of two-late stage trials.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390VA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OZEM","KLRA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":-0.1405},{"period":"1month","weight":-0.0849},{"period":"3month","weight":-0.2449},{"period":"6month","weight":-0.0094},{"period":"ytd","weight":-0.0094}],"compareEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.0099},{"period":"3month","weight":0.0107},{"period":"6month","weight":0.138},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1221}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kailera Therapeutics, Inc. was incorporated under the laws of Delaware on May 8, 2024. The company is a clinical-stage biotechnology company dedicated to ushering in a new era of obesity treatment through the advancement of a diversified R&D pipeline. It is currently rapidly advancing four clinical-stage product candidates that leverage multiple glucagon-like peptide-1 (GLP-1)-based mechanisms of action and routes of administration.","exchange":"NASDAQ","name":"Kailera Therapeutics","nameEN":"Kailera Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kailera Therapeutics(KLRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kailera Therapeutics,KLRA,Kailera Therapeutics股票,Kailera Therapeutics股票老虎,Kailera Therapeutics股票老虎国际,Kailera Therapeutics行情,Kailera Therapeutics股票行情,Kailera Therapeutics股价,Kailera Therapeutics股市,Kailera Therapeutics股票价格,Kailera Therapeutics股票交易,Kailera Therapeutics股票购买,Kailera Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kailera Therapeutics(KLRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction